Recruitment Details

Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details

Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups

	Description
Bimatoprost 0.03% Solution	No text entered.
Vehicle Solution	No text entered.

Participant Flow:   Overall Study

	Bimatoprost 0.03% Solution	Vehicle Solution
STARTED	137	141
COMPLETED	131	126
NOT COMPLETED	6	15
Adverse Event	4	4
Lost to Follow-up	0	3
Withdrawal by Subject	1	0
Protocol Violation	0	2
Sponsor Request - Conflict of Interest	0	2
Personal Reasons	1	4

Reporting Groups

	Description
Bimatoprost 0.03% Solution	No text entered.
Vehicle Solution	No text entered.

Baseline Measures

	Bimatoprost 0.03% Solution	Vehicle Solution	Total
Number of Participants   [units: participants]	137	141	278
Age, Customized   [units: participants]
<45 years	44	43	87
Between 45 and 65 years	82	88	170
>65 years	11	10	21
Gender   [units: participants]
Female	134	136	270
Male	3	5	8

1.  Primary:

Percentage of Participants Experiencing at Least a 1-grade Increase on the Global Eyelash Assessment (GEA) Scale From Baseline to Week 16   [ Week 16 ]

2.  Primary:

Percentage of Participants Experiencing at Least a 1-grade Increase on the Global Eyelash Assessment (GEA) Scale From Baseline to Week 20 (Post-treatment)   [ Week 20 ]

3.  Secondary:

Upper Eyelash Length as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 16   [ Week 16 ]

4.  Secondary:

Upper Eyelash Length as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 20 (Post-treatment)   [ Week 20 ]

5.  Secondary:

Upper Eyelash Thickness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 16   [ Week 16 ]

6.  Secondary:

Upper Eyelash Thickness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 20 (Post-treatment)   [ Week 20 ]

7.  Secondary:

Upper Eyelash Darkness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 16   [ Week 16 ]

8.  Secondary:

Upper Eyelash Darkness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 20 (Post-treatment)   [ Week 20 ]

9.  Other Pre-specified:

Patient Reported Outcome: Overall Satisfaction With Eyelashes (Single Item) in Terms of Change From Baseline to Week 16   [ Week 16 ]

10.  Other Pre-specified:

Patient Reported Outcome: Overall Satisfaction With Eyelashes (Single Item) in Terms of Change From Baseline to Week 20 (Post-treatment)   [ Week 20 ]